全球花生油酸市場－2026-2031年預測

全球花生油酸市場預計將從 2025 年的 274,543,000 美元成長到 2031 年的 354,962,000 美元，複合年成長率為 4.37%。

花生油酸(ARA) 是一種長鏈ω-6多元多不飽和脂肪酸(20:4 n-6)，在嬰幼兒營養和運動營養補充劑這兩個高價值領域中仍然是一種重要的功能性成分。作為細胞膜的主要結構成分，特別是在神經、視網膜、免疫和骨骼肌組織中，ARA 在早期發育和嚴重生理壓力條件下是一種條件必需脂肪酸。市售 ARA 主要透過控制產油真菌高山毛黴 (Mortierella alpinee) 的發酵生產，得到一種含有 40-50% ARA 的單細胞油，然後進行提純和標準化處理。

主要成長要素

1.花生油酸(ARA) 與二十二碳六烯酸 (DHA) 聯合使用，經監管部門核准並標準化後，已成為全球高階嬰兒配方奶粉和較大嬰兒配方奶粉的標準成分。歐盟法規明確授權使用源自高山毛黴 (Mortierella alpina) 的奶粉作為嬰兒奶粉、較大嬰兒配方奶粉和某些特殊醫學用途食品中的 ARA 來源。越來越多的科學共識表明 ARA 在早期神經發育和免疫成熟中發揮著重要作用，這持續推動著已開發市場和新興市場對 ARA 的需求不斷成長。

2. 運動營養和表現的擴展：受控臨床試驗表明，ARA 能夠促進瘦體重增加、峰值功率輸出和訓練引起的合成代謝訊號，這使其成為力量和爆發力類別中的一種差異化成分，尤其受到尋求非激素增效劑的阻力訓練者的需求。

3. 微生物油生產的持續創新。主要生產商（BASF、CABIO、透過原嘉吉/武漢夥伴關係的帝斯曼以及湖北復興生物技術有限公司）不斷提高發酵產量、油純度和永續性指標，確保高純度ARA油的穩定供應和具有競爭力的價格。

區域趨勢

北美市場持續維持主導，主要原因如下：

• 優質嬰兒奶粉人均消費量高
• 積極的研發活動已獲得多項與ARA在嬰幼兒營養和運動表現領域應用相關的專利。
• 運動營養在力量型運動員中的快速發展
• 墨西哥出生率上升以及美國嬰兒奶粉市場持續擴大

歐洲的成長速度僅次於北美，位居第二，這主要得益於監管部門的明確批准以及消費者對強化嬰幼兒營養品的強勁信心。亞太地區的銷售成長速度最快，這主要得益於中國、印度和東南亞中產階級對高階嬰幼兒奶粉的需求不斷成長，以及新興運動營養品類的成長。

花生油酸市場持續受益於其雙重角色：既是嬰幼兒必需營養素，也是成人運動表現增強補充劑。隨著高山毛黴油的成熟、規模化生產和監管已通過核准，花生四烯酸的供應限制已解除。預計市場成長將持續，這得益於嬰幼兒營養品的優質化、消費者對針對性運動補充劑的接受度不斷提高，以及花生四烯酸在女性健康和臨床營養領域應用潛力的拓展——在這些領域，花生四烯酸在細胞膜流動性和類花生酸訊號傳導中的作用具有顯著優勢。

本報告的主要優勢：

• 深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
• 競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略打入市場的潛力。
• 市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
• 可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
• 受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及影響、新產品開發、競爭影響

分析範圍

• 歷史資料（2021-2025 年）和預測資料（2026-2031 年）
• 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
• 競爭對手定位、策略和市場佔有率分析
• 按業務板塊和地區（國家）分類的收入成長和預測分析
• 公司概況（策略、產品、財務資訊、關鍵趨勢等）

目錄

第1章執行摘要

第2章市場概述

• 市場概覽
• 市場定義
• 分析範圍
• 市場區隔

第3章 商業情境

• 市場促進因素
• 市場限制
• 市場機遇
• 波特五力分析
• 產業價值鏈分析
• 政策和法規
• 策略建議

第4章 技術展望

5. 全球花生油酸市場（按原始材料類型分類）

• 介紹
• 動物源性
• 植物來源

6. 全球花生油酸市場（依形態分類）

• 介紹
• 烘乾
• 液體

7. 全球花生油酸市場依應用領域分類

• 介紹
• 嬰幼兒營養食品
• 營養補充品
• 製藥
• 其他

8. 全球花生油酸市場（按地區分類）

• 介紹
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他
• 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 其他
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 以色列
  • 其他
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 印尼
  • 泰國
  • 其他

第9章：競爭格局與分析

• 主要企業和策略分析
• 市佔率分析
• 企業合併、協議、商業合作
• 競爭對手儀錶板

第10章：公司簡介

• Cargill Incorporated
• Cabio Biotech（Wuhan）Co.., Ltd
• Cayman Chemicals
• DSM-Firmenich
• Merck KgaA
• Avanti Research（Croda International Plc.）
• Guangdong Runke Bioengineering Co., Ltd
• Bio-Techne Corporation
• HiMedia Laboratories LLC
• Tokyo Chemical Industry

第11章附錄

• 貨幣
• 先決條件
• 基準年和預測年時間表
• 相關人員的主要收益
• 分析方法
• 簡稱

Global Arachidonic Acid Market is expected to grow at a 4.37% CAGR, increasing to USD 354.962 million in 2031 from USD 274.543 million in 2025.

Arachidonic acid (ARA), a long-chain omega-6 polyunsaturated fatty acid (20:4 n-6), remains a critical functional ingredient in two high-value segments: infant nutrition and sports performance supplementation. As a key structural component of cell membranes, particularly in neural, retinal, immune, and skeletal muscle tissues, ARA is conditionally essential during early development and periods of intense physical stress. Commercial ARA is predominantly produced via controlled fermentation of the oleaginous fungus Mortierella alpina, yielding single-cell oils containing 40-50 % ARA that are subsequently refined and standardized.

Primary Growth Drivers

1. Regulatory acceptance and standardization in infant nutrition ARA, in combination with docosahexaenoic acid (DHA), is now a standard addition to premium infant and follow-on formulas worldwide. EU legislation explicitly authorizes oil derived from Mortierella alpina as a source of ARA for infant formula, follow-on formula, and foods for special medical purposes. Growing scientific consensus on the role of ARA in early neurodevelopment and immune maturation continues to drive inclusion rates in both developed and emerging markets.

2. Expanding sports nutrition and performance segment Controlled clinical studies demonstrating ARA's ability to support lean mass gains, peak power output, and training-induced anabolic signaling have established it as a differentiated ingredient in the strength and power athlete category. Demand is particularly strong among resistance-trained individuals seeking non-hormonal ergogenic aids.

3. Sustained innovation in microbial oil production Leading producers (BASF, CABIO, DSM via the former Cargill/Wuhan partnership, and Hubei Fuxing Biotechnology) continue to improve fermentation yields, oil purity, and sustainability metrics, ensuring stable supply and competitive pricing for high-purity ARA oils.

Regional Dynamics

North America maintains market leadership through a combination of:

• High per-capita consumption of premium infant formula
• Intense R&D activity resulting in numerous patents for ARA applications in early-life nutrition and sports performance
• Rapidly growing sports nutrition sector targeting strength athletes
• Rising fertility rates in Mexico and continued premiumization of the U.S. infant formula market

Europe follows closely, supported by clear regulatory authorization and strong consumer trust in fortified infant nutrition. Asia-Pacific exhibits the fastest unit growth, driven by expanding middle-class demand for premium infant formula in China, India, and Southeast Asia, alongside emerging sports nutrition categories.

The arachidonic acid market continues to benefit from its dual role as both an essential early-life nutrient and a performance-enhancing supplement for adults. With Mortierella alpina-derived oils now representing a mature, scalable, and regulator-approved source, ARA supply is no longer a constraint. Growth will be sustained by ongoing premiumization of infant nutrition, increasing consumer acceptance of targeted sports supplements, and potential pipeline extensions into women's health and clinical nutrition applications where ARA's role in membrane fluidity and eicosanoid signaling offers differentiated benefits.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Arachidonic Acid Market Segmentation:

• By Source Type
• Animal-Based
• Plant-Based
• By Form Type
• Dry
• Liquid
• By Application
• Infant Nutrition
• Dietary Supplements
• Pharmaceuticals
• Others
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL ARACHIDONIC ACID MARKET BY SOURCE TYPE

• 5.1. Introduction
• 5.2. Animal-Based
• 5.3. Plant-Based

6. GLOBAL ARACHIDONIC ACID MARKET BY FORM TYPE

• 6.1. Introduction
• 6.2. Dry
• 6.3. Liquid

7. GLOBAL ARACHIDONIC ACID MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Infant Nutrition
• 7.3. Dietary Supplements
• 7.4. Pharmaceuticals
• 7.5. Others

8. GLOBAL ARACHIDONIC ACID MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Israel
  • 8.5.4. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Cargill Incorporated
• 10.2. Cabio Biotech (Wuhan) Co.., Ltd
• 10.3. Cayman Chemicals
• 10.4. DSM-Firmenich
• 10.5. Merck KgaA
• 10.6. Avanti Research (Croda International Plc.)
• 10.7. Guangdong Runke Bioengineering Co., Ltd
• 10.8. Bio-Techne Corporation
• 10.9. HiMedia Laboratories LLC
• 10.10. Tokyo Chemical Industry

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations